BioCanCell Presents Final Data from Phase 2 Study of BC-819 for Early Stage Bladder Cancer at the 2018 ASCO Genitourinary Cancers Symposium – CBI
Homepage /  Press Release /  BioCanCell Presents Final Data from Phase 2 Study of BC-819 for Early Stage Bladder Cancer at the 2018 ASCO Genitourinary Cancers Symposium

Press Release

BioCanCell Presents Final Data from Phase 2 Study of BC-819 for Early Stage Bladder Cancer at the 2018 ASCO Genitourinary Cancers Symposium